Fundraising FoxSaisei Ventures — Full Portfolio
6 tracked investments · listed companies and verified rows first
Craif develops biomarker analysis and AI-driven diagnostic solutions to enable early disease detection and personalized treatment through non-invasive testing of body fluids.
AI & Machine LearningBiotechHealthtechMedical DevicesTokyo, JP
Ryuichi Onose(Founder)inYuki Ichikawa(Director)Mika Yui(Director)Ryuichi Onose Takao Yasui(Founder)
Co-investors1955 CapitalGlobal BrainAozora Corporate InvestmentDreamers VC
.png){kind=logo}
CureApp HT is a smartphone application that helps patients manage hypertension through self-monitoring of blood pressure and lifestyle changes, with supporting guidance from physicians.
AI & Machine LearningDigital HealthHealthtechMedical DevicesTokyo, JP
Kohta Satake, MD, MPH, MBA(Founder)in
Co-investorsBeyond Next VenturesKeio Innovation Initiative
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.
BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US
Akira Matsuno(Co-Founder, President, CFO, COO)inDerek Jantz(Executive Officer)inCharles Gersbach(Co-Founder)inJohn McHutchison(CEO, Chairman of the Board)inDan McHugh(Co-Founder, Investor)inBlythe Sather(Executive Officer)in
Co-investorsDuke Capital PartnersHatteras Venture PartnersMission BiocapitalNew Enterprise Associates (NEA)Pappas CapitalRV Invest GmbH+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Kenai TherapeuticsNotch TherapeuticsUnited Immunity
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.